Another recent study reported that PTPN6 is capable of decreasing prostate cancer cell proliferation and enhancing apoptosis, thus revealing that it can be a potential therapeutic target for prostate cancer [52]. The gene discussed is PTPN6; the disease is Familial prostate cancer.